WebBiotheranostics was acquired by Hologic in February 2024, and continues to offer its portfolio of proprietary genomic assays to support personalized disease management in … Biotheranostics Nondiscrimination Notice. Download our PDF to view this notice in … “The BCI Clinical Database for Correlative Studies represents a detailed … WebApr 16, 2024 · This Medicare contractor will provide limited coverage for the Breast Cancer Index® (BCI) gene expression test (Biotheranostics, Inc., San Diego, CA). The BCI test is used by physicians to provide a genomic-based estimate of distant recurrence risk when considering addition of chemotherapy, and/or late distant recurrence risk and endocrine ...
Biotheranostics, Inc. A Hologic Company
WebMay 2, 2024 · Biotheranostics. May 02, 2024, 09:00 ET. SAN DIEGO, May 2, 2024 /PRNewswire/ -- A recent analysis from the newly developed Breast Cancer Index (BCI) Clinical Database for Correlative Studies was ... WebBiotheranostics, Inc. has been acquired by Hologic. Hologic is an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. While we discover and ... fluoride in white tea
Breast Cancer Index® (BCI) NeoGenomics Laboratories
WebOct 2, 2013 · In a recent validation study, researchers involved in developing Biotheranostics' Breast Cancer Index test have found that the BCI outperformed Genomic Health's Oncotype DX in predicting longer-term recurrence risk, as well as early recurrence risk in a subgroup of HER2-negative WebJan 19, 2024 · Contact Data Lisa Whitmyer Biotheranostics, Inc. 216-513-7808 [email protected] WebOct 29, 2024 · Catherine Schnabel, Ph.D., Chief Scientific Officer, Biotheranostics, said, “Results from the IDEAL study represent a major milestone for BCI in regards to evidentiary rigor and to better align ... fluoride in your water